FTI Consulting
FCN
$150.60
-2.54%
FTI Consulting, Inc. is a global business advisory firm providing professional services across five segments: Corporate Finance, Forensic and Litigation Consulting, Economic Consulting, Technology, and Strategic Communications. The company is a recognized leader in complex restructuring, disputes, and investigations, serving a diverse client base across sectors including financial institutions, energy, healthcare, and technology. The current investor narrative is centered on a perceived disconnect between the stock's recent price weakness and the company's record financial performance, as highlighted by a major institutional investor's significant $183 million bet, suggesting potential undervaluation and confidence in the firm's resilience and earnings power despite broader market volatility.…
FCN
FTI Consulting
$150.60
Related headlines
Investment Opinion: Should I buy FCN Today?
Rating & Thesis: Hold. FCN presents a complex dichotomy of strong fundamentals trapped within a broken technical chart, making it a 'show me' story where the price action needs to confirm the underlying business strength before a Buy rating is warranted. The sparse analyst sentiment is neutral, and without a consensus price target, the thesis relies on the company proving it can stabilize its stock price.
Supporting Evidence: The recommendation is supported by four key data points: 1) The attractive forward P/E of 14.03x implies strong earnings growth, 2) Revenue growth remains healthy at 10.71% YoY, 3) The balance sheet is robust with a D/E of 0.34 and strong FCF generation of $166.6M, and 4) The stock is trading near the lower end of its annual range, just 9.7% above its 52-week low, which historically can be an area of value. However, these are counterbalanced by a high PEG of 4.41 and a severe -31.7% one-year relative strength versus the SPY.
Risks & Conditions: The two biggest risks are the continuation of the technical downtrend and a failure to meet the high implied forward earnings growth. This Hold would upgrade to a Buy if the stock reclaims and holds above the $175-$180 resistance zone on sustained volume, signaling a trend reversal, or if the forward P/E compresses further toward 12x while growth remains intact. It would downgrade to a Sell if quarterly net income declines further sequentially or if the price breaks decisively below the $140.84 support level. On balance, the stock appears fairly valued relative to its own history but carries a growth premium that demands flawless execution.
Sign up to view all
FCN 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The investment thesis is bifurcated: the fundamentals scream value, but the price action signals distress. The high forward earnings growth expectation embedded in the valuation is the linchpin; if achieved, the stock is deeply undervalued, but any stumble could justify the current bearish sentiment. The large institutional purchase is a compelling counter-signal, but it has not yet arrested the downtrend. The stance would upgrade to bullish on a confirmed technical reversal above $180, supported by stable quarterly earnings. It would turn bearish on a breakdown below $141, which would indicate the fundamental story is cracking.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FTI Consulting's 12-month outlook, with a consensus price target around $195.78 and implied upside of +30.0% versus the current price.
Average Target
$195.78
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$120 - $196
Analyst target range
Analyst coverage for FTI Consulting appears limited, with data indicating coverage from only one firm, which is insufficient to establish a robust consensus. The single analyst provides an estimated EPS of $11.92 for the period, with revenue estimates averaging $4.54 billion, but no consensus price target or recommendation distribution is available in the provided dataset. The lack of broad analyst coverage is typical for mid-cap companies and can lead to higher volatility and less efficient price discovery, as the stock may be less scrutinized by the institutional investment community. Recent institutional rating actions show a mix of sentiment; Truist Securities downgraded the stock from Buy to Hold in April 2025, while Goldman Sachs has maintained a Neutral rating, indicating a cautious to neutral stance among the few firms that do publish research on the name.
Bulls vs Bears: FCN Investment Factors
The bull case for FCN is anchored in strong fundamental performance—10.7% revenue growth, robust free cash flow, and a healthy balance sheet—which starkly contrasts with its severe technical downtrend and market underperformance. The bear case emphasizes this persistent price weakness, recent earnings volatility, and elevated valuation ratios like the PEG of 4.41, which question the stock's growth-adjusted appeal. Currently, the bearish technical evidence appears stronger, as the stock's price action has decisively diverged from its fundamentals for an extended period. The single most important tension in the investment debate is whether the recent $183 million institutional bet correctly identifies a profound valuation disconnect and imminent mean reversion, or if the technical breakdown and high PEG ratio correctly signal deeper, undisclosed operational challenges that justify the sell-off.
Bullish
- Strong Revenue Growth and Record Performance: Q4 2025 revenue grew 10.71% YoY to $990.7 million, with sequential quarterly growth from $898.3M to $990.7M throughout the year, demonstrating solid demand. This record financial performance contrasts sharply with the stock's price weakness, suggesting a potential valuation disconnect.
- Robust Free Cash Flow and Healthy Balance Sheet: The company generated $166.6 million in TTM free cash flow, enabling internal funding of operations and buybacks. A debt-to-equity ratio of 0.34 and a current ratio of 1.56 indicate a strong, low-leverage financial position with ample liquidity.
- Attractive Forward P/E Implies Earnings Growth: The forward P/E of 14.03x is significantly below the trailing P/E of 20.52x, implying the market expects a 31.6% increase in earnings. This forward multiple offers a more compelling valuation if the company meets its earnings projections.
- Major Institutional Investor Confidence: A recent $183 million institutional bet highlights strong confidence in the company's resilience and earnings power despite the stock's 16% one-year drop. This action signals a belief in significant upside potential from current levels.
Bearish
- Severe Technical Downtrend and Underperformance: The stock is down 9.44% over six months and 5.19% over one year, drastically underperforming the SPY's +10.0% and +26.53% gains. Trading just 9.7% above its 52-week low of $140.84, it shows persistent selling pressure and negative momentum.
- Recent Profitability Volatility and Margin Pressure: Q4 2025 net income of $54.5M declined sharply from $82.8M in Q3, and the quarterly gross margin of 31.05% dipped below the TTM average of 32.13%. This indicates potential earnings volatility and cost pressures that could concern investors.
- Limited Analyst Coverage and Neutral Sentiment: Analyst coverage is sparse, with only one firm providing estimates, leading to less efficient price discovery. Recent rating actions include a downgrade from Buy to Hold by Truist Securities, reflecting a cautious institutional stance.
- High PEG Ratio Suggests Overvaluation for Growth: A PEG ratio of 4.41 is exceptionally high, indicating the stock's price may not be justified by its expected earnings growth rate. This metric suggests the market has already priced in significant future growth, limiting upside.
FCN Technical Analysis
The stock is in a pronounced downtrend, having declined -5.19% over the past year and -9.44% over the last six months, significantly underperforming the SPY, which gained +26.53% and +10.0% over the same periods, respectively. Currently trading at $154.66, the price sits just 9.7% above its 52-week low of $140.84 and 18.3% below its 52-week high of $189.3, positioning it in the lower quartile of its annual range and suggesting the stock is in a state of technical weakness, potentially offering a value entry point but also indicating persistent selling pressure. Recent momentum has been sharply negative, with a -7.97% decline over the past month and a -6.56% drop over three months, which contrasts with the SPY's gains of +5.05% and +10.7% over the same periods, underscoring severe relative underperformance and accelerating negative momentum diverging from the broader market. Key technical support is firmly established at the 52-week low of $140.84, while resistance lies at the 52-week high of $189.30; a decisive break below support could signal a continuation of the downtrend, whereas a recovery above the recent breakdown levels near $175-$180 is needed to suggest stabilization. The stock's beta of 0.001 indicates it has exhibited virtually no correlation with market movements recently, which is unusual for a professional services firm and may point to idiosyncratic factors driving its price action, though this low beta reading should be interpreted with caution given the significant price swings evident in the data.
Beta
-0.05
-0.05x market volatility
Max Drawdown
-23.1%
Largest decline past year
52-Week Range
$141-$189
Price range past year
Annual Return
-6.7%
Cumulative gain past year
| Period | FCN Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | +0.3% |
| 3m | -11.1% | +12.3% |
| 6m | -14.7% | +8.9% |
| 1y | -6.7% | +24.0% |
| ytd | -11.6% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCN Fundamental Analysis
FTI Consulting's revenue trajectory shows consistent growth, with Q4 2025 revenue of $990.7 million representing a 10.71% year-over-year increase, and sequential quarterly revenue has risen from $898.3M in Q1 to $990.7M in Q4, indicating solid demand for its advisory services. The Corporate Finance segment is the largest revenue contributor at $423.2 million, followed by Forensic and Litigation Consulting ($192.9M) and Economic Consulting ($176.2M), with Technology and Strategic Communications providing more modest contributions. The company is profitable, reporting Q4 2025 net income of $54.5 million and a trailing twelve-month net margin of 7.15%, though profitability has fluctuated quarter-to-quarter, with net income declining from $82.8M in Q3 to $54.5M in Q4. Gross margin for Q4 2025 was 31.05%, slightly below the trailing gross margin of 32.13%, indicating some potential pressure on service delivery costs or mix, while the operating margin for the quarter was 9.43%. The balance sheet is healthy with a strong current ratio of 1.56 and a conservative debt-to-equity ratio of 0.34, indicating low financial leverage and ample liquidity. The company generated robust free cash flow of $166.6 million (TTM) and an ROE of 15.62%, demonstrating efficient capital allocation and the ability to fund operations and shareholder returns (via buybacks) internally without relying on debt.
Quarterly Revenue
$990746000.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$166577000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCN Overvalued?
Given its positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E stands at 20.52x, while the forward P/E is significantly lower at 14.03x, implying the market expects a substantial 31.6% growth in earnings over the next year, based on consensus estimates. Compared to industry averages (not explicitly provided in the data, but typical for consulting services), a trailing P/E of 20.5x appears reasonable to slightly elevated, though the forward multiple suggests a more attractive growth-adjusted valuation if earnings projections are met. Historically, the stock's own P/E ratio has ranged from a low near 15.4x (Q3 2025) to a high of 34.8x (Q4 2024), with the current 20.5x sitting near the midpoint of this two-year range, suggesting the stock is neither historically cheap nor expensive on this metric. The Price-to-Sales ratio of 1.47x and EV/Sales of 1.38x provide additional context, indicating the market values the company at approximately 1.4 times its annual sales, which is a moderate multiple for a profitable, asset-light services business.
PE
20.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is earnings volatility, as evidenced by net income dropping from $82.8M in Q3 to $54.5M in Q4 2025—a 34% sequential decline. While the balance sheet is strong with low debt (D/E of 0.34), the company faces margin pressure, with the Q4 gross margin of 31.05% below its TTM average. Revenue concentration is moderate, with the Corporate Finance segment contributing 43% of total revenue, creating some vulnerability to a downturn in restructuring or M&A activity. The valuation itself poses a risk, as a high forward earnings growth expectation (implied by the P/E compression from 20.5x to 14.0x) must be met to justify the current price.
Market & Competitive Risks: The stock trades at a significant valuation premium on a growth-adjusted basis, with a PEG ratio of 4.41, creating substantial compression risk if growth disappoints. Its severe underperformance versus the market (beta of 0.001 indicates idiosyncratic factors) suggests it is out of favor, which could persist. Competitive risks are inherent in the consulting industry, where client relationships and talent retention are key. The lack of broad analyst coverage (only one firm) exacerbates these risks, as negative news or an earnings miss could trigger disproportionate selling due to lower liquidity and visibility.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current downtrend, catalyzed by a significant earnings miss in the upcoming quarter that validates bearish concerns about margin pressure and growth sustainability. This could trigger analyst downgrades and a loss of institutional confidence, leading to a re-test and break below the key technical support at the 52-week low of $140.84. Given the stock's recent max drawdown of -23.14%, a realistic adverse scenario could see a decline of 20-25% from the current price of $154.66, targeting a range of $116 to $124, which would align with a deeper historical valuation trough near a P/E of 12-13x.
FAQ
The key risks are, in order of severity: 1) Technical & Sentiment Risk: The stock is in a pronounced downtrend, down 5.19% over the past year while the market rallied 26.53%, indicating persistent selling pressure that could continue. 2) Execution Risk: The company must deliver on the high implied earnings growth (31.6%) embedded in its forward P/E; a miss could cause multiple compression. 3) Profitability Risk: Recent quarterly net income volatility (Q4 $54.5M vs. Q3 $82.8M) and margin pressure raise concerns about earnings quality. 4) Liquidity & Coverage Risk: Limited analyst coverage can lead to higher volatility and inefficient price discovery.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock consolidating between $155 and $175 as fundamentals remain strong but sentiment stays muted. The Bull Case (25% probability) targets $189 to $210, driven by earnings beats and a valuation re-rating. The Bear Case (15% probability) warns of a drop to $125-$141 if earnings disappoint and support breaks. The Base Case is most likely, assuming the company meets its growth targets but fails to quickly repair its damaged chart. The key assumption is that net income stabilizes in the $60-$80M quarterly range.
FCN sends mixed valuation signals. On a trailing P/E basis at 20.52x, it is fairly valued relative to its own two-year historical range. The forward P/E of 14.03x suggests the market expects strong growth, making it appear undervalued if those expectations are met. However, the extremely high PEG ratio of 4.41 indicates it is significantly overvalued relative to its growth rate. The Price-to-Sales ratio of 1.47x is moderate for a services firm. Overall, the stock is not clearly cheap; the market is paying a premium for anticipated future earnings growth that the company must now deliver.
FCN is a speculative buy for investors with a high risk tolerance and a long-term horizon. The 31.6% implied earnings growth (from the forward P/E of 14.03x) offers significant upside if achieved, and the stock is trading just 9.7% above its 52-week low. However, it is not a good buy for short-term traders or risk-averse investors, given its severe technical downtrend (-9.44% over 6 months), earnings volatility, and high PEG ratio of 4.41. The recent $183 million institutional bet suggests smart money sees value, but retail investors should wait for confirmation of a price bottom and earnings stability.
FCN is unsuitable for short-term trading due to its high volatility, negative momentum, and low beta that suggests idiosyncratic, unpredictable price moves. It is better suited for a long-term investment horizon of 2-3 years, allowing time for the fundamental strength to eventually be reflected in the share price and for the technical downtrend to fully reverse. The lack of a dividend means total return relies solely on price appreciation. Given the current disconnect, patient investors buying at these levels are effectively making a contrarian bet on mean reversion, which typically requires a longer time frame to play out.